MSC-derived exosomes

BIOLOGICAL4 trials

Sponsors

Huazhong University of Science and Technology, Research Institute for Gastroenterology and Liver Diseases (RIGLD), Biocells Medical, Al Salam University

Conditions

Alveolar Bone LossBone RegenerationDecompensated Liver CirrhosisLong COVID-19 SyndromeMultiple SclerosisTooth Extraction

Early Phase 1

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After COVID-19

Huazhong University of Science and TechnologyLong COVID-19 Syndrome

Start: 2023-02-15End: 2025-02-15Target: 80Updated: 2023-04-14

Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis

SuspendedNCT07146087

Biocells MedicalMultiple Sclerosis

Start: 2020-07-01End: 2027-12-31Target: 20Updated: 2025-08-28

Phase 1

Evaluation of Stem Cell Exosomes Versus Platelet-Rich Fibrin in Tooth Extraction Socket Healing

RecruitingNCT07508033

Al Salam UniversityAlveolar Bone Loss, Bone Regeneration, Tooth Extraction

Start: 2026-01-15End: 2026-08-01Target: 40Updated: 2026-04-02

Phase 2

Effect of Mesenchymal Stem Cells-derived Exosomes in Decompensated Liver Cirrhosis

Research Institute for Gastroenterology and Liver Diseases (RIGLD)Decompensated Liver Cirrhosis

Start: 2023-05-26End: 2023-12-11Target: 15Updated: 2023-05-23